Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.047 SGD | +9.30% | +11.90% | +4.44% |
Mar. 12 | Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer | MT |
Mar. 12 | IX Biopharma Introduces New Sublingual Wafer | MT |
Business Summary
Number of employees: 45
Sales per Business
SGD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Specialty Pharmaceutical
87.3
%
| 14 | 95.7 % | 5 | 87.3 % | -62.51% |
Nutraceutical
12.7
%
| 1 | 4.3 % | 1 | 12.7 % | +21.39% |
Sales per region
SGD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
86.6
%
| 1 | 9.5 % | 5 | 86.6 % | +273.05% |
China
9.8
%
| 1 | 3.6 % | 1 | 9.8 % | +11.13% |
Singapore
2.0
%
| 0 | 0.6 % | 0 | 2.0 % | +25.81% |
United States
1.6
%
| 12 | 86.2 % | 0 | 1.6 % | -99.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yip Hang Lee
CEO | Chief Executive Officer | - | 04-05-07 |
Sien Lup Chew
DFI | Director of Finance/CFO | 60 | 16-04-13 |
Chief Operating Officer | 45 | 16-03-31 | |
Iain Cook
CTO | Chief Tech/Sci/R&D Officer | - | 15-09-24 |
Stephen Lim
PRN | Corporate Officer/Principal | - | - |
Kuan Loong Lai
SEC | Corporate Secretary | 45 | - |
Soo Fern Lee
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yip Hang Lee
CEO | Chief Executive Officer | - | 04-05-07 |
Shing Tung Ho
BRD | Director/Board Member | 57 | 13-02-28 |
Patrick Davies
BRD | Director/Board Member | 57 | 19-12-01 |
Woon Keng Teo
BRD | Director/Board Member | 67 | 22-11-06 |
Xi Wen Tham
BRD | Director/Board Member | - | 22-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 768,317,356 | 376,567,123 ( 49.01 %) | 0 | 49.01 % |
Company contact information
iX Biopharma Ltd.
Great World City East Tower 1 Kim Seng Promenade
237994, Singapore
+
http://www.ixbiopharma.comSector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.44% | 26.76M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- 42C Stock
- Company iX Biopharma Ltd.